Advanced search
Publication Cover
Scandinavian Journal of Clinical and Laboratory Investigation Volume 80, 2020 - Issue 1
Submit an article Journal homepage
104
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Diagnostic value of soluble programmed cell death protein-1 in type-1 autoimmune hepatitis in Egyptian children

Ola G. BehairyPediatrics Department, Faculty of Medicine, Benha University, Benha, Egypt;
,
Eman G. BehiryClinical Pathology Department, Faculty of Medicine, Benha University, Benha, Egypt; Correspondence[email protected]
,
Manal S. El DefrawyPediatrics Department, Faculty of Medicine, Benha University, Benha, Egypt;
&
Ahmed N. El AdlyM.B.B.CH, Benha University, Benha, Egypt
Pages 59-65 | Received 26 Sep 2019, Accepted 17 Nov 2019, Published online: 25 Nov 2019

References

  • Pathak S, Kamat D. Autoimmune hepatitis in children. Pediatr Ann. 2018;47(2):e81–e86.
  • Liberal R, Vergani D, Mieli-Vergani G. Update on autoimmune hepatitis. J Clin Transl Hepatol. 2015;3(1):42.
  • Heneghan MA, Yeoman AD, Verma S, et al. Autoimmune hepatitis. Lancet. 2013;382(9902):1433–1444.
  • Zamani MR, Aslani S, Salmaninejad A, et al. PD-1/PD-L and autoimmunity: a growing relationship. Cellul Immunol. 2016;310:27–41.
  • Aarslev K, Dige A, Greisen SR, et al. Soluble programmed death-1 levels are associated with disease activity and treatment response in patients with autoimmune hepatitis. Scand J Gastroenterol. 2017;52(1):93–99.
  • Hennes EM, Zeniya M, Czaja AJ, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008;48(1):169–176.
  • Manns MP, Czaja AJ, Gorham JD, et al. Diagnosis and management of autoimmune hepatitis. Hepatology. 2010;51(6):2193–2213.
  • Huo TI, Lin HC, Wu JC, et al. Proposal of a modified Child‐Turcotte‐Pugh scoring system and comparison with the model for end‐stage liver disease for outcome prediction in patients with cirrhosis. Liver Transpl. 2006;12(1):65–71.
  • Freeman RB, Jr Wiesner RH, Roberts JP, et al. Improving liver allocation: MELD and PELD. Am J Transplant. 2004;4:114–131.
  • Pedoeem A, Azoulay-Alfaguter I, Strazza M, et al. Programmed death-1 pathway in cancer and autoimmunity. J Clin Immunol. 2014;153(1):145–152.
  • Behairy OG. Characteristics of autoimmune hepatitis in a sample of Egyptian children. Egypt Pediatr Assoc Gazette. 2017;65(4):108–113.
  • Mataki N, Kikuchi K, Kawai T, et al. Expression of PD-1, PD-L1, and PD-L2 in the liver in autoimmune liver diseases. Am J Gastroenterol. 2007;102(2):302.
  • Curran CS, Sharon E. PD-1 immunobiology in autoimmune hepatitis and hepatocellular carcinoma. Semin Oncol. 2017;44(6):428–432.
  • Agina HA, Ehsan NA, Abd-Elaziz TA, et al. Hepatic expression of programmed death-1 (PD-1) and its ligand, PD-L1, in children with autoimmune hepatitis: relation to treatment response. Clin Exp Hepatol. 2019;5(3):256.
  • Wang D, Zhou DA, Du Q, et al. Aberrant production of soluble inducible T-cell co-stimulator (sICOS) and soluble programmed cell death protein 1 (sPD-1) in patients with chronic hepatitis C. Mol Med Rep. 2013;7(4):1197–1202.
  • Wan B, Nie H, Liu A, et al. Aberrant regulation of synovial T cell activation by soluble costimulatory molecules in rheumatoid arthritis. J Immunol. 2006;177(12):8844–8850.
  • Czaja AJ. Under-evaluated or unassessed pathogenic pathways in autoimmune hepatitis and implications for future management. Dig Dis Sci. 2018;63(7):1706–1725.
  • Pen JJ, Keersmaecker BD, Heirman C, et al. Interference with PD-L1/PD-1 co-stimulation during antigen presentation enhances the multifunctionality of antigen-specific T cells. Gene Ther. 2014;21(3):262.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.